{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T05:07:17Z","timestamp":1738991237600,"version":"3.37.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2000,1,1]],"date-time":"2000-01-01T00:00:00Z","timestamp":946684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2000,1]]},"DOI":"10.4065\/75.1.86","type":"journal-article","created":{"date-parts":[[2009,1,24]],"date-time":"2009-01-24T01:17:28Z","timestamp":1232759848000},"page":"86-97","source":"Crossref","is-referenced-by-count":8,"title":["Antimicrobial Therapy for Infants and Children: Guidelines for the Inpatient and Outpatient Practice of Pediatric Infectious Diseases"],"prefix":"10.4065","volume":"75","author":[{"given":"Nancy K.","family":"Henry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay L.","family":"Hoecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. Hable","family":"Rhodes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"1998","series-title":"1998-1999 Pocket Book of P\u00e9diatrie Antimicrobial Therapy","author":"Nelson","key":"10.4065\/75.1.86_bib1"},{"key":"10.4065\/75.1.86_bib2","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0891-5520(20)30285-3","article-title":"Antimicrobial agents in pediatrics","volume":"3","author":"Mustafa","year":"1989","journal-title":"infect Dis Clin North Am"},{"key":"10.4065\/75.1.86_bib3","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/infdis\/132.6.637","article-title":"Pharmaco-kinetics of gentamicin in children and adults","volume":"132","author":"Slber","year":"1975","journal-title":"J Infect Dis"},{"key":"10.4065\/75.1.86_bib4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00006454-199002000-00009","article-title":"The use of antibiotics in neonates weighing less than 1200 grams","volume":"9","author":"Prolwr","year":"1990","journal-title":"Pediatr infect Dis J"},{"key":"10.4065\/75.1.86_bib5","series-title":"Nelson Textbook of Pediatrics","first-page":"1520","article-title":"Drug doses","author":"Cohen","year":"1987"},{"key":"10.4065\/75.1.86_bib6","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0022-3476(81)80670-1","article-title":"Pharmacokinelics of chloramphenicol and chloramphenicol succinate in infants and children","volume":"98","author":"Kauffman","year":"1981","journal-title":"J Pediatr"},{"key":"10.4065\/75.1.86_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3476(61)80204-7","article-title":"Toxicity of drugs in the neonatal period","volume":"59","author":"Nyhan","year":"1961","journal-title":"J Pediatr"},{"key":"10.4065\/75.1.86_bib8","series-title":"NeoFax: A Manual of Drugs Used in Neonatal Care","first-page":"2","author":"Young","year":"1999"},{"key":"10.4065\/75.1.86_bib9","unstructured":"Vlrk A, Steckelberg JM. Clinical aspects of antimicrobial resistance. Mayo Chn Proc [in press]"},{"key":"10.4065\/75.1.86_bib10","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1345\/aph.17228","article-title":"Ampicillin-induced neurotoxicity in very-low-birth-weight neonates","volume":"32","author":"Shaffer","year":"1998","journal-title":"Ann Pharmacother"},{"key":"10.4065\/75.1.86_bib11","series-title":"1997 Red Book: Report of the Committee on Infectious Diseases","first-page":"494","article-title":"Group 8 streptococcal infections","author":"American Academy of Pediatrics","year":"1997"},{"key":"10.4065\/75.1.86_bib12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4065\/74.2.187","article-title":"The cephalosporins","volume":"74","author":"Marshall","year":"1999","journal-title":"Mayo Clin Proc"},{"key":"10.4065\/75.1.86_bib13","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/00006454-198609000-00013","article-title":"Cross-sensitivity of cephalosporins in patients allergic to penicillin","volume":"5","author":"Anderson","year":"1986","journal-title":"Pediatr Infect Dis"},{"key":"10.4065\/75.1.86_bib14","series-title":"1997 Red Book: Report of the Committee on Infectious Diseases","first-page":"390","article-title":"Pelvic inflammatory disease","author":"American Academy of Pediatrics","year":"1997"},{"key":"10.4065\/75.1.86_bib15","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/00006454-198309000-00017","article-title":"Cefuroxime: a cephalosporin with unique applicability to p\u00e9diatrie practice","volume":"2","author":"Nelson","year":"1983","journal-title":"Pediatr Infect Dis"},{"key":"10.4065\/75.1.86_bib16","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJM198608283150905","article-title":"A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia","volume":"315","author":"Pino","year":"1986","journal-title":"N Engl J Med"},{"key":"10.4065\/75.1.86_bib17","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/00006454-199002000-00006","article-title":"Five years of cefotaxime use in a neonatal intensive care unit","volume":"9","author":"Spritzer","year":"1990","journal-title":"Pediatr infect Dis J"},{"key":"10.4065\/75.1.86_bib18","series-title":"1997 Red Book: Report of the Committee on Infectious Diseases","first-page":"410","article-title":"Pneumococcal infections","author":"American Academy of Pediatrics","year":"1997"},{"key":"10.4065\/75.1.86_bib19","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/0016-5085(91)90667-A","article-title":"Ceftriaxone associated gallbladder sludge: identification of calcium-cefthaxone salt as a major component of gallbladder precipitate","volume":"100","author":"Park","year":"1991","journal-title":"Gastroenterology"},{"key":"10.4065\/75.1.86_bib20","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S0140-6736(88)90596-X","article-title":"Reversible ceftriaxone-associated biliary pseudolithiasis in children","volume":"2","author":"Schaad","year":"1988","journal-title":"Lancet"},{"key":"10.4065\/75.1.86_bib21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1542\/peds.98.1.133","article-title":"Ceftriaxone choledocholithiasis","volume":"98","author":"Robertson","year":"1996","journal-title":"Pediatrics"},{"key":"10.4065\/75.1.86_bib22","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/jac\/19.6.823","article-title":"Bilirubin displacement by ceftriaxone in neonates: evaluation by determination of \u201cfree\u201d bilirubin and erythrocyte-bound bilirubin","volume":"19","author":"Gullan","year":"1987","journal-title":"J Antimicrob Chemother"},{"key":"10.4065\/75.1.86_bib23","first-page":"369","article-title":"Cefepime: the next generation?","volume":"17","author":"Sanders","year":"1993","journal-title":"Clin Infect Dis"},{"key":"10.4065\/75.1.86_bib24","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1128\/AAC.27.2.265","article-title":"In vitro studies or BMY-2B142. a new broad-spectrum cephalosporin","volume":"27","author":"Bodey","year":"1985","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 6A","key":"10.4065\/75.1.86_bib25","first-page":"68S","article-title":"Safety of cefepime: a new extended-spectrum parenteral cephalosporin","volume":"100","author":"Neu","year":"1996","journal-title":"AmJMed"},{"key":"10.4065\/75.1.86_bib26","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/archpedi.1992.02160190029013","article-title":"Cefepime: pharmacokinetics and clinical response in patients with cystic fibrosis","volume":"146","author":"Arguedas","year":"1992","journal-title":"Am J Dis Child"},{"key":"10.4065\/75.1.86_bib27","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1128\/AAC.39.4.937","article-title":"Prospective randomized comparison of cefepime and cefotaxime for treatment of bacterial meningitis in infants and children","volume":"39","author":"Saez-Llorens","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/75.1.86_bib28","first-page":"284","article-title":"Cefepime vs. ceftriaxone for p\u00e9diatrie meningitis [abstract]","volume":"36","author":"O'Ryan","year":"1996","journal-title":"Program Abstr Intersci Conf Antimicrob Agents Chemother"},{"key":"10.4065\/75.1.86_bib29","doi-asserted-by":"crossref","first-page":"792500","DOI":"10.1093\/infdis\/154.5.792","article-title":"Type I beta-lactamases of gram-negative bacteria: interactions with beta-lactam antibiotics","volume":"154","author":"Sanders","year":"1986","journal-title":"J Infect Dis"},{"key":"10.4065\/75.1.86_bib30","first-page":"1153","article-title":"Imipenem\/cilastatin for the treatment of infections in hospitalized children","volume":"139","author":"Alpert","year":"1985","journal-title":"Am J Dis Child"},{"key":"10.4065\/75.1.86_bib31","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1128\/AAC.29.4.670","article-title":"Cerebrospinal fluid penetration of imipenem and cilastatin (Primaxin) in children with central nervous system infections","volume":"29","author":"Jacobs","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/75.1.86_bib32","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/00006454-199102000-00009","article-title":"Imipenem\/cilastatin treatment of bacterial meningitis in children","volume":"10","author":"Wong","year":"1991","journal-title":"Pediatr Infect Dis J"},{"key":"10.4065\/75.1.86_bib33","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/00006454-199509000-00014","article-title":"Safety of imipenem in neonates","volume":"14","author":"Stuart","year":"1995","journal-title":"Pediatr Infect Dis J"},{"key":"10.4065\/75.1.86_bib34","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/jac\/30.3.279","article-title":"Decreased susceptibility of penicillin-resistant pneumococci to twenty-four beta-lactam antibiotics","volume":"30","author":"Linares","year":"1992","journal-title":"J Antimicrob Chemother"},{"key":"10.4065\/75.1.86_bib35","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/00006454-199703000-00002","article-title":"Meropenem: a new, extremely broad spectrum beta-lactam antibiotic for serious infections in pediatrics","volume":"16","author":"Bradley","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"10.4065\/75.1.86_bib36","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/00006454-199608000-00036","article-title":"Empirical treatment of fever in neutropenic children: the role of the carbapenems","volume":"15","author":"Cometta","year":"1996","journal-title":"Pediatr Infect Dis J"},{"key":"10.4065\/75.1.86_bib37","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/00006454-199608000-00035","article-title":"Use of carbapenems and other antibiotics for pulmonary infections in patients with cystic fibrosis","volume":"15","author":"Hoiby","year":"1996","journal-title":"Pediatr Infect Dis J"},{"issue":"Suppl 14","key":"10.4065\/75.1.86_bib38","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0022-3476(83)80737-9","article-title":"Renal clearance of gentamicin in cystic fibrosis","volume":"103","author":"MacDonak)","year":"1983","journal-title":"J Pediatr"},{"key":"10.4065\/75.1.86_bib39","first-page":"137","article-title":"Safety and efficacy of tobramycin solution for inhalation in patients with cystic fibrosis","volume":"14","author":"Ramsey","year":"1997","journal-title":"Pediatr Pulmonol"},{"key":"10.4065\/75.1.86_bib40","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1086\/314727","article-title":"Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis","volume":"179","author":"Burns","year":"1999","journal-title":"J Infect Dis"},{"key":"10.4065\/75.1.86_bib41","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/106002809002400313","article-title":"Aminoglycoside volume of distribution in p\u00e9diatrie patients","volume":"24","author":"Shevchuk","year":"1990","journal-title":"DICP"},{"key":"10.4065\/75.1.86_bib42","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/jac\/26.4.469","article-title":"Risk\/benefit analysis of quinolone use in children: the effect on diarthrodial joints","volume":"26","author":"Maggiolo","year":"1990","journal-title":"J Antimicrob Chemfr ther"},{"key":"10.4065\/75.1.86_bib43","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00006454-199701000-00031","article-title":"Sequential ciprofloxacin therapy in p\u00e9diatrie cystic fibrosis: comparative study vs ceftazidime\/tobramycin in the treatment of acute pulmonary exacerbations","volume":"16","author":"Church","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"10.4065\/75.1.86_bib44","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/00006454-199701000-00033","article-title":"Pharmacokinetic disposition of sequential intravenous\/oral ciprofloxacin in p\u00e9diatrie cystic fibrosis patients with acute pulmonary exacerbations","volume":"16","author":"Rublo","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"10.4065\/75.1.86_bib45","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/BF01644970","article-title":"Safety of ciprofloxacin in children: worldwide clinical experience based on compassionate use; emphasis on joint evaluation","volume":"19","author":"Chysky","year":"1991","journal-title":"Infection"},{"key":"10.4065\/75.1.86_bib46","series-title":"1997 Red Book: Report of the Committee on Infectious Diseases","first-page":"605","article-title":"Antimicrobials and related therapy","author":"American Academy of Pediatrics","year":"1997"},{"key":"10.4065\/75.1.86_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00006454-199901000-00002","article-title":"Acute otitis media: management and surveillance in an era of pneumococcal resistance-a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group [published erratum appears in Pediatr Infect Dis J 1999;18:34i]","volume":"18","author":"Dowell","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"10.4065\/75.1.86_bib48","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1542\/peds.101.4.658","article-title":"Single-dose and steady-state pharmacokinetics of a new oral suspension of ciprofloxacin in children","volume":"101","author":"Peltola","year":"1998","journal-title":"Pediatrics"},{"key":"10.4065\/75.1.86_bib49","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1542\/peds.47.3.567","article-title":"Tetracyclines and permanent teeth: the relation between dose and tooth color","volume":"47","author":"Grossman","year":"1971","journal-title":"Pediatrics"},{"key":"10.4065\/75.1.86_bib50","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1001\/archpedi.1963.02080040455005","article-title":"Growth inhibition of prematures receiving tetracydine: a clinical and laboratory investigation of letracy-cline-induced bone fluorescence","volume":"105","author":"Cohlan","year":"1963","journal-title":"Am J Dis Child"},{"key":"10.4065\/75.1.86_bib51","series-title":"1997 Red Book: Report of the Committee on Infectious Diseases","first-page":"196","article-title":"Ehrlichiosis (human)","author":"American Academy of Pediatrics","year":"1997"},{"key":"10.4065\/75.1.86_bib52","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/S0025-6196(11)64004-4","article-title":"Antimycobacterial therapy","volume":"74","author":"Van Scoy","year":"1999","journal-title":"Mayo Clin Proc"},{"key":"10.4065\/75.1.86_bib53","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1164\/ajrccm.149.5.8173779","article-title":"Treatment of tuberculosis and tuberculosis infection in adults and children","volume":"149","author":"Bass","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.4065\/75.1.86_bib54","series-title":"1997 Red Book: Report of the Committee on Infectious Diseases","first-page":"541","article-title":"Tuberculosis","author":"American Academy of Pediatrics","year":"1997"},{"key":"10.4065\/75.1.86_bib55","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.4065\/73.12.1205","article-title":"Antifungal agents. Parti. Amphotericin B preparations and flucytosine","volume":"73","author":"Patel","year":"1998","journal-title":"Mayo Clin Proc"},{"key":"10.4065\/75.1.86_bib56","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1056\/NEJM199903113401004","article-title":"Liposomal amphotericin B for empirical therapy in patients with persistent fever end ne-utropenia","volume":"340","author":"Walsh","year":"1999","journal-title":"N Engl J Med"},{"key":"10.4065\/75.1.86_bib57","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/00006454-199908000-00010","article-title":"Amphotericin B lip complex in p\u00e9diatrie patients with invasive fungal infections","volume":"18","author":"Walsh","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"10.4065\/75.1.86_bib58","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4065\/74.1.78","article-title":"Antifungal agents. Part II. The azoles","volume":"74","author":"Terrell","year":"1999","journal-title":"Mayo Clin Proc"},{"key":"10.4065\/75.1.86_bib59","series-title":"Handbook of P\u00e9diatrie HIV Care","first-page":"531","article-title":"Pneumocystis carinii infection","author":"Serchuck","year":"1999"},{"key":"10.4065\/75.1.86_bib60","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.4065\/74.12.1266","article-title":"Antiviral agents for non-human immunodeficiency virus infections","volume":"74","author":"Keating","year":"1999","journal-title":"Mayo Clin Proc"},{"key":"10.4065\/75.1.86_bib61","series-title":"1997 Red Book: Report of the Committee on Infec tious Diseases","first-page":"187","article-title":"Cytomegalovirus infection","author":"American Academy of Pediatrics","year":"1997"},{"key":"10.4065\/75.1.86_bib62","series-title":"1997 Red Book; Report of the Committee on Infectious Diseases","first-page":"247","article-title":"Hepatitis B","author":"American Academy of Pediatrics","year":"1997"},{"key":"10.4065\/75.1.86_bib63","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/00006454-199908000-00008","article-title":"Retreatment with higher dose interferon alpha in children with chronic hepatitis B infection","volume":"18","author":"Ozen","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"10.4065\/75.1.86_bib64","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1056\/NEJM199709253371302","article-title":"Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections","volume":"337","author":"Hayden","year":"1997","journal-title":"N Engl J Med"},{"key":"10.4065\/75.1.86_bib65","first-page":"137","article-title":"Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections","volume":"97","author":"American Academy of Pediatrics Committee on Infectious Diseases","year":"1996","journal-title":"Pediatrics"},{"key":"10.4065\/75.1.86_bib66","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1542\/peds.102.3.531","article-title":"Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospital ization from respiratory syncytial virus infection in high-risk infants","volume":"102","author":"Impact-RSV Study Group","year":"1998","journal-title":"Pediatrics"},{"key":"10.4065\/75.1.86_bib67","first-page":"18","article-title":"New antiviral shows efficacy for viral meningitis","volume":"33","author":"ZoJer","year":"1999","journal-title":"Pediatr News"},{"key":"10.4065\/75.1.86_bib68","doi-asserted-by":"crossref","first-page":"12841301","DOI":"10.4065\/74.12.1284","article-title":"Antiretrovirals","volume":"74","author":"Temesgen","year":"1999","journal-title":"Mayo Clin Proc"},{"key":"10.4065\/75.1.86_bib69","series-title":"Handbook of P\u00e9diatrie HIV Care","first-page":"231","article-title":"Antiretroviral therapy","author":"McKlnney","year":"1999"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611642614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611642614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T05:57:34Z","timestamp":1738907854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619611642614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,1]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,1]]}},"alternative-id":["S0025619611642614"],"URL":"https:\/\/doi.org\/10.4065\/75.1.86","relation":{},"ISSN":["0025-6196"],"issn-type":[{"type":"print","value":"0025-6196"}],"subject":[],"published":{"date-parts":[[2000,1]]}}}